Toshiki Kino

Mangiferin suppresses CIA by suppressing the expression of TNF-α, IL-6, IL-1β, and RANKL through inhibiting the activation of NF-κB and ERK1/2.

Masanobu Tsubaki, T. Takeda, M. Imano, 2015, American journal of translational research.

Mangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway.

Masanobu Tsubaki, T. Takeda, M. Imano, 2016, International journal of oncology.

Statins improve survival by inhibiting spontaneous metastasis and tumor growth in a mouse melanoma model.

T. Takeda, M. Imano, T. Satou, 2015, American journal of cancer research.

Statins inhibited the MIP-1α expression via inhibition of Ras/ERK and Ras/Akt pathways in myeloma cells.

T. Takeda, M. Imano, T. Satou, 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Contributions of MET activation to BCR-ABL1 tyrosine kinase inhibitor resistance in chronic myeloid leukemia cells

K. Nishio, T. Takeda, M. Imano, 2017, Oncotarget.

Mangiferin induces apoptosis in multiple myeloma cell lines by suppressing the activation of nuclear factor kappa B-inducing kinase.

T. Takeda, M. Imano, T. Satou, 2016, Chemico-biological interactions.

The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin‐induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathways

T. Takeda, M. Imano, T. Satou, 2017, Clinical and experimental pharmacology & physiology.

Mangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway.

T. Takeda, M. Imano, T. Satou, 2016, International journal of oncology.

Mangiferin induces apoptosis in multiple myeloma cell lines by suppressing the activation of nuclear factor kappa B-inducing kinase.

T. Takeda, M. Imano, T. Satou, 2016, Chemico-biological interactions.